| A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life Setting (NCT05612841) | Centre Hospitalier Universitaire de Besancon | 2022-04-05 |
| EBRT + Lu-PSMA for N1M0 Prostate Cancer (NCT05162573) | The Netherlands Cancer Institute | 2021-12-20 |
| 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical (NCT04831307) | British Columbia Cancer Agency | 2021-08-30 |
| Urinary and Prostate Microbiotes and Prostate Cancer (NCT03947515) | Centre Hospitalier Universitaire de Nice | 2021-02-04 |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer (NCT04484701) | British Columbia Cancer Agency | 2021-02-01 |
| SLPI for Prostate Cancer (NCT04854343) | University of Florence | 2020-12-01 |
| Trial of NanoPac Focal Therapy for Prostate Cancer (NCT04221828) | NanOlogy, LLC | 2020-10-20 |
| Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors (NCT03935282) | Wake Forest University Health Sciences | 2020-10-01 |
| The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy (NCT05566405) | Sismanoglio General Hospital | 2020-07-27 |
| Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy (NCT04234399) | University of Vermont | 2020-03-01 |
| EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression (NCT04266431) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-20 |
| Prostate Cancer Genetic Risk Evaluation and Screening Study (NCT05129605) | Massachusetts General Hospital | 2020-02-12 |
| Organoids From Metastases of Prostate Cancer (NCT03952793) | Centre Antoine Lacassagne | 2019-12-04 |
| MSG Use With 18F-DCFPyL PET/CT Imaging (NCT03693742) | British Columbia Cancer Agency | 2019-11-04 |
| Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer (NCT03982095) | Azienda USL Reggio Emilia - IRCCS | 2019-09-04 |
| HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer (NCT04523896) | David Büchser | 2019-07-01 |
| I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). (NCT03939689) | Progenics Pharmaceuticals, Inc. | 2019-05-30 |
| The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients. (NCT04774133) | Regina Elena Cancer Institute | 2019-02-14 |
| Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit (NCT03183544) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-01-24 |
| Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors (NCT03343093) | University of Minnesota | 2019-01-01 |
| Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy (NCT03253744) | National Cancer Institute (NCI) | 2018-07-05 |
| 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer (NCT03490838) | Advanced Accelerator Applications | 2018-05-24 |
| Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate Cancer (NCT03693703) | Fondazione del Piemonte per l'Oncologia | 2018-04-18 |
| Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. (NCT03361969) | Pantarhei Oncology B.V. | 2018-04-16 |
| 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer (NCT03389451) | Michael Graham PhD, MD | 2018-02-16 |
| 68Ga PSMA in Preprostatectomy Patients (NCT03388346) | Michael Graham PhD, MD | 2018-02-16 |
| Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy (NCT03242265) | ATGen Canada Inc | 2017-04-04 |
| Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer (NCT03104907) | Rigshospitalet, Denmark | 2017-03-22 |
| An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma (NCT03061643) | Samsung Medical Center | 2017-02-08 |
| Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study (NCT02967458) | Thomas Jefferson University | 2017-02-01 |
| Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer (NCT03397030) | The University of Texas Health Science Center at San Antonio | 2017-01-05 |
| Urology of Virginia Case Series (NCT03035487) | Exact Imaging | 2016-12-01 |
| The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial (NCT02966535) | Seoul National University Hospital | 2016-11-01 |
| Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery (NCT02977143) | Seoul National University Hospital | 2016-11-01 |
| Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer (NCT06236789) | Yonsei University | 2016-11-01 |
| Treatment Patterns in Metastatic Prostate Cancer (NCT02729103) | Bayer | 2016-10-31 |
| Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique (NCT02687308) | Rio de Janeiro State University | 2016-03-01 |
| Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy (NCT02526589) | Tampere University Hospital | 2015-08-01 |
| Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START (NCT03348722) | Rete Oncologica Piemonte, Valle d'Aosta | 2015-05-15 |
| Carboplatin in Castration-resistant Prostate Cancer (NCT02311764) | Aurelius Omlin | 2015-02-01 |
| Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies (NCT02971995) | Lille Catholic University | 2014-12-01 |
| Detection Rate of Prostate Cancer in Men Undergoing MRI (NCT04398173) | Fondazione del Piemonte per l'Oncologia | 2014-11-01 |
| Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate (NCT01996696) | AHS Cancer Control Alberta | 2014-09-01 |
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer (NCT01431391) | Dendreon | 2011-09-01 |
| IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen (NCT01314118) | Janssen Biotech, Inc. | 2011-05-04 |
| A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer (NCT01337518) | Enzon Pharmaceuticals, Inc. | 2011-03-01 |
| Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer (NCT01540994) | Sharp HealthCare | 2011-01-01 |
| Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients (NCT01696539) | Örebro University, Sweden | 2010-03-01 |
| Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer (NCT00956228) | Mayo Clinic | 2006-10-01 |
| Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer (NCT00751790) | Debiopharm International SA | 2006-07-01 |
| Exercise for Physical Health in Men With Prostate Cancer (NCT00660686) | OHSU Knight Cancer Institute | 2006-01-01 |
| Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms (NCT00666926) | Verastem, Inc. | 2005-12-01 |
| Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial (NCT00247312) | Schiffler Cancer Center | 2005-10-01 |
| Dietary Factors and Racial Disparities in Prostate Cancer Aggressiveness (NCT03289130) | University of South Carolina | 2004-09-01 |
| Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer (NCT01081873) | Abbott | 2004-06-01 |
| CT/MRI Co-registration Prostate Cancer (NCT00252460) | University Health Network, Toronto | 2003-11-01 |
| Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer (NCT00174863) | Sanofi | 2003-10-01 |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy (NCT01316458) | Novartis Pharmaceuticals | 2003-06-01 |
| Preop Conformal Radiotherapy - Prostate (NCT00252447) | University Health Network, Toronto | 2000-05-01 |
| A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer (NCT00001446) | National Cancer Institute (NCI) | 1995-09-01 |
| A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms (NCT00001444) | National Cancer Institute (NCI) | 1995-08-01 |
| A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma (NCT00001266) | National Cancer Institute (NCI) | 1990-10-01 |